The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective

By Laughren T.P.  

European Psychiatry, Vol. 16, Iss. 7, 2001-11 ,pp. : 418-423

Elsevier

Access to resources Recommend Favorite

Cognitive behavior therapy for schizophrenia: A meta-analytical review of randomized controlled trials

By Sarin Freddy   Wallin Lennart   Widerlööv Birgitta  

Nordic Journal of Psychiatry, Vol. 65, Iss. 3, 2011-06 ,pp. : 162-174

Informa Healthcare

Access to resources Recommend Favorite

Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trials

By Barbui C.   Saraceno B.   Liberati A.   Garattini S.  

European Psychiatry, Vol. 11, Iss. 6, 1996-01 ,pp. : 306-313

Elsevier

Access to resources Recommend Favorite

Self-esteem in persons with schizophrenia. A Nordic multicentre study

By Sörgaard Knut W.   Heikkilä Jyrki   Hansson Lars   Vinding Hanne R.   Bjarnason Olafur   Bengtson-Tops Anita   Merinder Lars   Nilsson Liselott   Sandlund Mikael   Middelboe Thomas  

Journal of Mental Health, Vol. 11, Iss. 4, 2002-08 ,pp. : 405-415

Informa Healthcare

Access to resources Recommend Favorite

The Treatment of Schizophrenia: A Survey of the Literature

By Hinsie L.E.  

Psychiatric Quarterly, Vol. 70, Iss. 1, 1999-01 ,pp. : 5-26

Springer Publishing Company

Access to resources Recommend Favorite